AKERO THERAPEUTICS INC CVR from 00973Y108
13F holders, Q1 2026 (March 31)1holders −2
0new positions
2sold out
$0.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding AKERO THERAPEUTICS INC CVR from 00973Y108 in their 13F filings, down 2 from Q4 2025. 0 opened new positions and 2 sold out. The largest holder was Keating Financial Advisory Services, Inc. ($0).
- Company
- AKERO THERAPEUTICS INC CVR from 00973Y108
- CUSIP
- 009CVR044
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 550 shares sold, net −550 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Keating Financial Advisory Services, Inc. | 0.00% | No change | 28 | $0 |
"% of holder's portfolio" is AKERO THERAPEUTICS INC CVR from 00973Y108's weight in each manager's 13F, not the share of AKERO THERAPEUTICS INC CVR from 00973Y108 the manager owns.